Cosentyx (secukinumab)

pCPA File Number: 22861

Negotiation Status:

Under consideration for negotiation

Indication(s):

Hidradenitis Suppurativa

Sponsor/Manufacturer:

Novartis Pharmaceuticals Canada Inc.

CDA-AMC Project Number:

SR0781-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable